PP88 Exosome Hair Therapy: Regenerative Support for Thinning Hair in Hyderabad
Struggling with progressive follicle miniaturization, excessive hair fall, or scalp thinning? PP88 Exosome Hair Therapy is a specialized, medical-grade biostimulation protocol designed to rejuvenate sluggish hair follicles. Synergizing concentrated exosome vesicles with GHK-Cu copper peptides and cellular growth factors, PP88 creates an optimal micro-environment for hair shaft thickening and extended anagen growth. Schedule an expert consultation at Celestee Skin, Laser and Hair Clinic in Hyderabad.
What is PP88 Exosome Therapy?
PP88 is an advanced, standardized regenerative complex engineered specifically for scalp and follicle rehabilitation. The formulation harnesses purified extracellular nanovesicles (exosomes) derived from accredited, sterile biological cultures, reinforced with targeted trichological actives including GHK-Cu copper tripeptides, biomimetic peptides, amino acids, and essential vitamins.
Applied to the scalp via precision clinical microneedling or transdermal micro-infusion, PP88 acts as a biological catalyst. The microscopic exosome vesicles fuse directly with follicular dermal papilla cells, delivering cellular repair instructions that prolong the anagen (growth) phase, dampen local scalp micro-inflammation, and nourish weakened follicles to support thicker, stronger hair fibers.
The Four Key Active Pillars in the PP88 Formula
PP88 combines four biologically synergistic components to address hair thinning at the cellular level:
01. Purified Exosome Nanovesicles
Standardized exosome vesicles cross cellular membranes to deliver signaling microRNAs and signaling proteins directly to the hair bulb. This stimulates the Wnt/β-catenin regenerative pathway, waking dormant follicles and encouraging metabolic reactivation in miniaturizing hair shafts.
02. GHK-Cu Copper Tripeptides
Copper peptide (GHK-Cu) is a clinically documented active that enlarges hair follicle size and stimulates extracellular matrix collagen around the hair bulb. Research also demonstrates its mild inhibitory effect on local 5-alpha reductase, helping shield follicles from androgenic stress.
03. Recombinant Biomimetic Growth Factors (VEGF & bFGF)
Vascular Endothelial Growth Factor (VEGF) and basic Fibroblast Growth Factor (bFGF) stimulate the formation of new micro-capillary networks around thinned hair roots. This ensures maximum oxygen, glucose, and amino acid delivery to the highly metabolic hair matrix cells.
04. Biotinoyl Tripeptide-1 & Anti-Inflammatory Actives
Biotinoyl Tripeptide-1 strengthens the anchoring molecules in the outer root sheath (laminin 5 and collagen IV), cementing the hair shaft firmly within the follicle dermis to resist premature physical shedding and breakage during grooming.
Clinical Indications for PP88 Exosome Therapy
Targeted regenerative biostimulation for thinning scalp zones across men and women.
Indication 01
Temporal & Frontal Hairline
Supports miniaturizing follicles along the hairline margins, reinforcing hair caliber before permanent loss occurs.
Indication 02
Crown & Vertex Thinning
Nourishes expanding crown thinning patterns in male and female androgenetic hair loss, restoring scalp coverage.
Indication 03
Diffuse Telogen Effluvium
Calms widespread rapid shedding following acute physical or emotional stress, fever, or postpartum hormone shifts.
Indication 04
Post-Transplant Native Hair
Fortifies existing non-transplanted native hair follicles surrounding surgical recipient zones to prevent shock loss.
Who is a good candidate for PP88 Exosome Therapy?
PP88 is indicated for individuals experiencing active hair thinning who still possess viable, living follicles. Candidates typically include:
- Men and women with mild to moderate pattern hair loss (Norwood Stages 2 to 4, Ludwig Stages 1 to 2).
- Individuals experiencing diffuse thinning across the scalp with visible scalp reflection under light.
- Postpartum mothers experiencing excessive shedding months after delivery.
- Patients who have reached a plateau with conventional PRP and want a multi-active peptide booster.
- Patients experiencing early hair miniaturization who want to delay or avoid surgical intervention.
- Individuals seeking to combine evidence-based in-clinic regenerative therapy with home Minoxidil or Finasteride regimens.
Clinical Candidacy Limitations: Who is NOT Suited?
We believe in complete transparency. PP88 is a biostimulant, not a miracle cure. It is not suitable for:
Complete, Long-Standing Baldness
Areas that have been shiny and devoid of hair for years have lost their follicular stem cells. PP88 requires existing follicles to deliver regenerative instructions. Completely bald zones require surgical hair transplantation.
Active Cicatricial (Scarring) Alopecias
Autoimmune inflammatory conditions that destroy follicles (such as Lichen Planopilaris or Frontal Fibrosing Alopecia) must first be clinically stabilized with medical dermatology before biostimulants can be evaluated.
An Honest Note on PP88 Evidence, Regulation & Safety
Evidence Status: Exosome-based hair biostimulation is an emerging field with compelling biological mechanisms documented in preclinical and animal trials. While clinical data—including Indian dermatological pilot studies—shows positive improvements in hair shaft thickness and shedding reduction, large double-blind human clinical trials are currently ongoing worldwide. We do not promise overnight miracles or guaranteed results; therapeutic outcomes differ depending on individual genetics and hormonal balance.
Regulatory Status & Sterility: Exosome hair products are not FDA-approved drugs for baldness; Indian regulatory frameworks for advanced biologics continue to evolve. At Celestee Clinics, all PP88 formulations are sterile-processed, batch-certified, and free from animal pathogens, ensuring maximum clinical safety during delivery.
What are the clinical signs that PP88 addresses?
- Miniaturized, fine, and wispy hair strands lacking tensile strength.
- Widening central parting line in women.
- Noticeable thinning across the crown vertex in men.
- Shedding of more than 100 hairs daily during brushing or showering.
- Compromised scalp barrier, chronic dryness, or mild perifollicular erythema.
- Sluggish hair growth following systemic illness or nutritional stress.
- Loss of overall ponytail density or volume.
- Early family history of androgenetic alopecia with early onset symptoms.
How is the PP88 treatment performed at Celestee?
Our senior dermatologists utilize a standardized medical protocol to ensure comfort and uniform biological delivery:
- Digital Scalp Trichoscopy: High-resolution micro-camera evaluation to map miniaturization percentages and baseline follicle density.
- Antiseptic Scalp Prep: Thorough medical cleansing of the treatment zone with optional topical numbing for sensitive patients.
- Precision Microneedle Delivery: Automated micro-channeling creates superficial micro-pores (0.5mm to 1.0mm) across the thinning zones.
- PP88 Infusion & Peptides: The fresh PP88 exosome and copper peptide complex is infused directly into the micro-channels for deep follicular absorption.
Expected Timeline & Clinical Milestones
Hair growth is biological and gradual. What to expect over your treatment cycle.
Trichoscopy Follicular Evolution
*Individual responses vary based on age, duration of hair loss, and underlying hormone balance. Optimal results are achieved when combined with medical trichology management.
Consult With Our Senior Dermatologists & Trichologists
Personalized hair restoration overseen by certified dermatological specialists.
Dr. Raj Kirit E.P.
Senior Aesthetic Dermatologist and Hair Transplant Surgeon with over 15 years of experience in clinical trichology, advanced regenerative biologics, and surgical restoration.
Dr. Sridevi. P.
Renowned consultant dermatologist specializing in medical scalp disorders, female pattern hair loss, and regenerative follicle stimulation with an evidence-based approach.
How many PP88 sessions do I need, and what is the aftercare?
A complete course generally comprises 3 to 5 sessions spaced 3 to 4 weeks apart. Most patients observe an initial reduction in shedding around 4 to 8 weeks, with noticeable textural improvement and density evaluated between 3 to 6 months.
Post-treatment aftercare is straightforward:
- Keep the scalp dry and do not wash hair for at least 12 to 24 hours after the procedure.
- Avoid intense workouts, heavy sweating, saunas, and swimming pools for 48 hours.
- Do not apply topical Minoxidil or other scalp serums for 24 hours post-session.
- Avoid scratching, picking, or vigorous brushing over the treated areas.
- Postpone chemical hair treatments (coloring, straightening) for 7 days.
- Protect the treated scalp from direct harsh sunlight using a clean, loose cap.
Frequently Asked Questions: PP88 Exosome Therapy
Clear medical answers to help you understand PP88 hair therapy in Hyderabad.
